Kuala Lumpur, 21 May 2026 – KPJ Healthcare Berhad (“KPJ Healthcare” or “the Group”) today reported a strong set of results for the first quarter ended 31 March 2026, delivering solid top‑line and earnings growth as the Group continues to accelerate its transformation under the KPJ Health System (“KPJHS”).

First Quarter FY2026 Results

Financial Performance

Revenue rose 9% year-on-year to RM1,050 million.
EBITDA increased 11% to RM233.3 million, translating into an EBITDA margin of 22.2%.
PATAMI rose 22% year-on-year to RM69.6 million, with a PATAMI margin of 6.6%, driven by improved revenue intensity, disciplined cost management and the early benefits of system-led integration under KPJHS.

Operational Performance

Average revenue per inpatient went up 6% and average revenue per outpatient increased by 7%, supported by improved case mix and sustained demand for more complex treatments and specialised services.
Inpatient admissions grew 2% to 88,863.
Outpatient visits increased 1% to 695,332.
Surgeries increased 2% to 27,565.
Bed occupancy rate (“BOR”) stood at 60%, moderated by additional operational capacity introduced during the quarter.

Dividend

The Group declared an interim dividend of 1.00 sen per share, totalling RM44.3 million, payable on 17 July 2026.

Chin Keat Chyuan, President and Managing Director of KPJ Healthcare said, “KPJ has delivered a strong start to FY2026, with healthy revenue growth, improved earnings and higher revenue intensity, reflecting the early returns of our shift toward system-led value creation. More significant than the quarterly performance is the structural repositioning of the Group under our 2026–2030 Strategic Plan and the KPJHS. We are steadily transitioning from an expansion-led growth model to a system-led, value-creation model, focused on building an integrated, higher-acuity health system through Centres of Excellence, digital and AI enablement, academic partnerships and tighter operational integration. Importantly, the strength of KPJ lies in the institution, capabilities and integrated system being built across the Group. This is what will sustain earnings quality, lift system-wide efficiency and create durable shareholder value over the long term. Throughout, we remain firmly committed to our ‘Care for Life’ purpose.”

Highlights

The Group’s Q1 2026 developments reflected the continued execution of its Strategic Plan 2026-2030, anchored by KPJHS as the transformation engine and the KPJ Care Network as the integrated delivery platform.

The five-year strategy, which marks KPJ’s transition from a group of standalone hospitals into Malaysia’s first private Academic Health System, continued to gain momentum in Q1 2026 through initiatives that strengthened clinical capabilities, healthcare accessibility and community impact across the Group, including:

Demonstrating clinical leadership, KPJ launched its first Neuroscience and Stroke Centre of Excellence (“CoE”) at Damansara Specialist Hospital 2 (“DSH2”), the second CoE established under KPJHS.
Showcasing advanced procedures, Johor Specialist Hospital ("JSH") successfully performed a Complex High Indication Percutaneous Coronary Intervention ("CHIP PCI"), a specialised form of angioplasty for severe, high-risk coronary artery disease, using Intravascular Lithotripsy ("IVL") technology at its Heart and Lung CoE. It also successfully conducted its first Minimally Invasive Cardiac Surgery, reinforcing the Group's capabilities in advanced cardiac care.

The collaboration between **Dr Mohd Shahrom Ujang** (left) and Dr Zul Hilmi Yaakob reflects a structured proctorship and knowledge transfer between two specialist hospitals.

Tawakkal Specialist Hospital (“TSH”) successfully completed KPJ’s first kidney transplant in recent years, marking an important milestone in the Group’s clinical capabilities.

Tawakkal Specialist Hospital successfully completed KPJ’s first renal transplant in recent years, marking an important milestone in the Group’s clinical capabilities.

The appointment of Professor Dato’ Dr Hanafiah Harunarashid as Chief Medical Director (“CMD”) further strengthened clinical governance and leadership across the Group.
Underscoring external recognition, KPJ garnered 10 awards at the Healthcare Asia Awards, the highest number among Malaysian healthcare groups, including the flagship "Hospital Group of the Year – Malaysia", reinforcing its regional leadership in private healthcare.

KPJ garnered 10 awards at the Healthcare Asia Awards 2026, the highest number among Malaysian healthcare groups.

The KPJ Cares App was named Gold Winner in the Innovation in Health, Wellness and Lifestyle Apps category at the 2026 Asia-Pacific Stevie Awards, reflecting the Group's ongoing advancement in patient-centric digital innovation.
Klinik Waqaf An-Nur (“KWAN”) digitalised operations across seven static clinics and two mobile clinics, strengthening patient record management, medical reporting and delivery of community healthcare services for underserved communities, with 14,704 patients treated during Q1 FY2026.

Representing KPJ Healthcare’s commitment to accessible and compassionate care, Klinik Waqaf An-Nur continues to serve communities through affordable healthcare initiatives under KPJ’s CSR programme.

Q2 2026 Operational Updates

As Malaysia’s first private health system, KPJ continues to advance the KPJHS transformation agenda across practice, education, research and innovation, with a particular focus on the convergence of artificial intelligence, genomics and value‑based care.

In the current quarter, KPJ is recalibrating its entire business ecosystem — spanning clinical operating model, governance, digital and AI backbone, academic and research platforms, operating structure and talent architecture, commercial engine and strategic partnerships — to ensure full alignment with the objectives of KPJHS.

Among the current initiatives, KPJ has established the KPJHS Governing Council and the Future Health Institute Executive Council. The Group has also commenced the development of a new health information system, continued targeted recruitment efforts to attract leading clinical, research and innovation talent, including Malaysians abroad, deepened collaborations with world-class institutions such as the Royal College of Surgeons of England and Mayo Clinic, and sharpened its approach to capturing opportunities in health tourism. These initiatives will continue into the second and third quarters of 2026 and are expected to be reflected through the launch of additional CoEs and the Future Health Institute. Collectively, these initiatives are designed to embed KPJHS as a durable institutional capability that strengthens the Group across business cycles and supports long-term sustainability.

Operating environment and outlook

Bank Negara Malaysia projects Malaysia’s gross domestic product growth at 4% to 5% for 2026, supported by continued domestic demand and export. The Ministry of Health’s decision to defer the implementation of the Diagnosis Related Group payment system for private hospitals to 2027 provides additional clarity and allows the ecosystem more time to prepare for a smoother, more sustainable transition.

Looking ahead, we expect the external environment to remain fluid amid ongoing geopolitical tensions. While no material direct impact on the Group has been observed thus far, we will continue to monitor developments closely and take mitigating actions where necessary.

This content is provided by KPJ Healthcare Berhad

The views expressed here are those of the author/contributor and do not necessarily represent the views of Malaysiakini.

Interested in having your press releases, exclusive interviews, or branded content articles on Malaysiakini? For more information, contact [email protected] or [email protected]